Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.10.3.1 (
tyrosinase
)
9,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
To study the induction of differentiation in human melanoma cells, we treated 12 melanoma cell lines with mycophenolic acid and tiazofurin, inhibitors of
IMP dehydrogenase
(
IMPDH
). In all cell lines studied, both agents inhibited cell growth and increased melanin content. However, the degree of growth inhibition did not necessarily correspond to the increase in melanin content. A detailed analysis of the HO and SK-MEL-131 cell lines indicated that mycophenolic acid and tiazofurin caused a time- and dose-dependent increase in the expression of a series of other maturation markers, including formation of dendrite-like structures,
tyrosinase
activity, and reactivity with the CF21 monoclonal antibody. The growth inhibition and melanogenesis induced by the
IMPDH
inhibitors was abrogated by the addition of exogenous guanosine. No such effect was observed after treatment of the cells with phorbol 12-myristate 13-acetate or retinoic acid, two other inducers of differentiation in these cells. The mycophenolic acid- and tiazofurin-treated cells also showed an increased level of
IMPDH
mRNA and protein, perhaps because of compensation for the inhibitor-mediated decrease in
IMPDH
activity. In contrast, treatment with phorbol 12-myristate 13-acetate or retinoic acid resulted in decreased levels of
IMPDH
mRNA and protein. The lack of a consistent pattern of
IMPDH
expression in the cells treated with
IMPDH
inhibitors and phorbol 12-myristate 13-acetate or retinoic acid suggests that the altered expression of
IMPDH
is not a general requirement for the induction of cell differentiation in these cells. Our results also suggest that
IMPDH
inhibitors may provide a useful approach to circumvent the differentiation block in melanoma.
...
PMID:Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase: altered patterns of IMP dehydrogenase expression and activity. 198 May 99